Optically active benzoquinolizine compounds, process for prepari

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544361, 546 95, A61K 31495, A61K 31435, C07D45504

Patent

active

049468448

ABSTRACT:
An optically active (+)-isomer of a benzoquinolizine compound of the formula [I], is provided: ##STR1## where X.sub.1 represents a halogen atom, and R.sub.1 and R.sub.2 represent lower alkyl groups, a physiologically acceptable salt thereof, or a hydrate of either of the foregoing compounds. The compounds [I]-(+) exhibit an excellent antibacterial activity. Also, the compounds exhibit high solubility in water. Therefore, the compounds of the present invention are usable for the treatment of infectious diseases and usable in aqueous liquid preparations such as injections.

REFERENCES:
patent: 4117229 (1978-09-01), Baker et al.
patent: 4195176 (1980-03-01), Baker et al.
patent: 4683341 (1987-07-01), Ishii et al.
patent: 4720495 (1988-01-01), Takagi et al.
patent: 4818394 (1989-04-01), Okamoto et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Optically active benzoquinolizine compounds, process for prepari does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Optically active benzoquinolizine compounds, process for prepari, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active benzoquinolizine compounds, process for prepari will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-960798

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.